Crossmark

Tocilizumab improves the proatherothrombotic profile of rheumatoid arthritis patients modulating endothelial dysfunction, NETosis, and inflammation

Crossref DOI link: https://doi.org/10.1016/j.trsl.2016.12.003

Published Print: 2017-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Ruiz-Limón, Patricia

Ortega, Rafaela

Arias de la Rosa, Ivan

Abalos-Aguilera, Maria del Carmen

Perez- Sanchez, Carlos

Jimenez- Gomez, Yolanda

Peralbo-Santaella, Esther

Font, Pilar

Ruiz-Vilches, Desiree

Ferrin, Gustavo

Collantes-Estevez, Eduardo

Escudero-Contreras, Alejandro

López- Pedrera, Chary

Barbarroja, Nuria
Funding

Funding for this research was provided by:

Junta de Andalucia (CTS-7940)

Junta de Andalucia (PI-0191-2013)

Spanish Rheumatology Foundation (PI15/01333 and CP15/00158)
License Information

Text and Data Mining valid from 2017-05-01
More Information

This article is maintained by: Elsevier

Article Title: Tocilizumab improves the proatherothrombotic profile of rheumatoid arthritis patients modulating endothelial dysfunction, NETosis, and inflammation

Journal Title: Translational Research

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.trsl.2016.12.003

Content Type: article

Copyright: © 2016 Elsevier Inc. All rights reserved.